AptarGroup, Inc.
ATR
Classement en actions
#2444
AptarGroup, Inc. specializes in developing and manufacturing solutions for... AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Prix de l'action
$125.90
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$8.00B
Changement (1 jour)
0.93%
Changement (1 an)
-3.58%
Pays
US
Échange AptarGroup, Inc. (ATR)
Catégorie
Healthcare
Ratio P/E pour AptarGroup, Inc. (ATR)
Ratio P/E au October 2026 TTM : 21.48
Selon les derniers rapports financiers et le cours de l'action de AptarGroup, Inc., le ratio P/E actuel (TTM) est de 21.48. À la fin de l’année 2024, le P/E de l’entreprise était de 27.82.
Historique du ratio P/E pour AptarGroup, Inc. de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 21.48 | 5.23% |
| 2025 | 20.41 | -26.64% |
| 2024 | 27.82 | -2.42% |
| 2023 | 28.51 | -5.15% |
| 2022 | 30.06 | -8.77% |
| 2021 | 32.95 | -20.03% |
| 2020 | 41.20 | 35.75% |
| 2019 | 30.35 | 0.63% |
| 2018 | 30.16 | 23.19% |
| 2017 | 24.48 | 9.11% |
| 2016 | 22.44 | -1.63% |
| 2015 | 22.81 | 0.60% |
| 2014 | 22.67 | -12.99% |
| 2013 | 26.06 | 33.74% |
| 2012 | 19.48 | 3.07% |
| 2011 | 18.90 | 2.36% |
| 2010 | 18.47 | -4.81% |
| 2009 | 19.40 | 24.53% |
| 2008 | 15.58 | -21.52% |
| 2007 | 19.85 | -0.82% |
| 2006 | 20.01 | 8.89% |
| 2005 | 18.38 | -10.15% |
| 2004 | 20.46 | 15.92% |
| 2003 | 17.65 | 5.07% |
| 2002 | 16.80 | -21.39% |
| 2001 | 21.37 | 30.90% |
| 2000 | 16.32 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 47.48 | 121.10% |
US
|
|
| 27.43 | 27.70% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 164.91% |
US
|
|
| - | - |
CH
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.